FPGT expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.563000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.834400E-01
Normal-vs-Stage2
4.801000E-01
Normal-vs-Stage3
9.622300E-03
Normal-vs-Stage4
4.030400E-01
Stage1-vs-Stage2
3.499000E-01
Stage1-vs-Stage3
4.805900E-02
Stage1-vs-Stage4
3.577400E-01
Stage2-vs-Stage3
5.046100E-02
Stage2-vs-Stage4
1.807610E-02
Stage3-vs-Stage4
5.499800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.512000E-01
Normal-vs-AfricanAmerican
9.869400E-01
Normal-vs-Asian
3.347200E-01
Caucasian-vs-AfricanAmerican
3.049800E-01
Caucasian-vs-Asian
6.252800E-01
AfricanAmerican-vs-Asian
2.525000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.303200E-01
Normal-vs-Female
6.062800E-01
Male-vs-Female
2.843800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.120000E-01
Normal-vs-Age(41-60Yrs)
6.699800E-01
Normal-vs-Age(61-80Yrs)
3.959800E-01
Normal-vs-Age(81-100Yrs)
3.417600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.333400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.803200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.777400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.181420E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.340000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.112000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.924390E-01
Normal-vs-Daily Drinker
3.716800E-01
Normal-vs-Weekly Drinker
1.354420E-01
Normal-vs-Occasional Drinker
8.700400E-01
Normal-vs-Social Drinker
4.310800E-01
Non Drinker-vs-Daily Drinker
8.362800E-01
Non Drinker-vs-Weekly Drinker
5.141400E-01
Non Drinker-vs-Occasional Drinker
5.416100E-02
Non Drinker-vs-Social Drinker
4.287600E-01
Daily Drinker-vs-Weekly Drinker
5.040800E-01
Daily Drinker-vs-Occasional Drinker
1.627420E-01
Daily Drinker-vs-Social Drinker
6.454000E-01
Weekly Drinker-vs-Occasional Drinker
4.702100E-02
Weekly Drinker-vs-Social Drinker
2.368600E-01
Occasional Drinker-vs-Social Drinker
3.446600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.303430E-01
Normal-vs-Grade 2
3.788400E-02
Normal-vs-Grade 3
3.473600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.719400E-03
Grade 1-vs-Grade 3
1.284460E-02
Grade 1-vs-Grade 4
1.303430E-01
Grade 2-vs-Grade 3
6.697800E-01
Grade 2-vs-Grade 4
3.788400E-02
Grade 3-vs-Grade 4
3.473600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.347400E-01
Normal-vs-NonDiabetic
3.223600E-01
Diabetic-vs-NonDiabetic
3.738600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.764600E-01
Normal-vs-NoPancreatitis
3.420600E-01
Pancreatitis-vs-NoPancreatitis
6.770400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.270600E-01
Normal-vs-N1
4.531400E-01
N0-vs-N1
9.655200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.659200E-01
Normal-vs-TP53-NonMutant
5.470000E-01
TP53-Mutant-vs-TP53-NonMutant
2.936200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
